Clinical trial
Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects…
NCT00203047 · Teva Branded Pharmaceutical Products R&D, Inc., Industry · Terminated
Key facts
| NCT number | NCT00203047 |
|---|---|
| Title | Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate |
| Official title | A Multi-Centered, Randomized, Double-Blind, Placebo Controlled Study Assessing the Add-on Effect of Oral Steroids in Relapsing Remitting Multiple Sclerosis Subjects Treated With Glatiramer Acetate (GA) |
| Acronym | ASSERT |
| Lead sponsor | Teva Branded Pharmaceutical Products R&D, Inc., Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Relapsing Remitting Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | Glatiramer Acetate, Placebo, Prednisone |
| Enrollment | 414 |
| Start date | Jan 1, 2005 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Sep 20, 2005 |
| Last update posted | Jan 6, 2014 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: